CD133 Expression at the Metastatic Site Predicts Patients' Outcome in Colorectal Cancer with Synchronous Liver Metastasis. (Q52886460)

9 May 2018

title

CD133 Expression at the Metastatic Site Predicts Patients' Outcome in Colorectal Cancer with Synchronous Liver Metastasis. (English)

1 reference

9 May 2018

1 reference

4

Kiyoshi Hasegawa

1 reference

9 May 2018

Norihiro Kokudo

26

Norihiro Kokudo

1 reference

9 May 2018

Eiji Sunami

22

Eiji Sunami

1 reference

9 May 2018

Toshiaki Watanabe

27

Toshiaki Watanabe

1 reference

9 May 2018

Masashi Fukayama

25

Masashi Fukayama

1 reference

9 May 2018

Hiroyuki Abe

7

Hiroyuki Abe

1 reference

9 May 2018

Tetsuo Ushiku

23

Tetsuo Ushiku

1 reference

9 May 2018

Shinsuke Kazama

2

Shinsuke Kazama

1 reference

9 May 2018

Kumiko Hongo

9

Kumiko Hongo

1 reference

9 May 2018

Toshiaki Tanaka

14

Toshiaki Tanaka

1 reference

9 May 2018

author name string

Junko Kishikawa

1

1 reference

9 May 2018

Koji Oba

3

1 reference

9 May 2018

Hiroyuki Anzai

5

1 reference

9 May 2018

Yuzo Harada

6

1 reference

9 May 2018

Keisuke Matsusaka

8

1 reference

9 May 2018

Masaru Oba

10

1 reference

9 May 2018

Koji Yasuda

11

1 reference

9 May 2018

Kensuke Otani

12

1 reference

9 May 2018

Takeshi Nishikawa

13

1 reference

9 May 2018

Junichiro Tanaka

15

1 reference

9 May 2018

Tomomichi Kiyomatsu

16

1 reference

9 May 2018

Keisuke Hata

17

1 reference

9 May 2018

Kazushige Kawai

18

1 reference

9 May 2018

Hiroaki Nozawa

19

1 reference

9 May 2018

Hironori Yamaguchi

20

1 reference

9 May 2018

Soichiro Ishihara

21

1 reference

9 May 2018

Joji Kitayama

24

1 reference

9 May 2018

publication date

29 January 2016

1 reference

9 May 2018

Annals of Surgical Oncology

published in

1 reference

9 May 2018

volume

23

1 reference

9 May 2018

page(s)

1916-1923

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-016-5099-1

exact match

0 references

cites work

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Population-based data from the Swedish Colon Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Cancer stem cell sorting from colorectal cancer cell lines by sedimentation field flow fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

CD133(-) cells, derived from a single human colon cancer cell line, are more resistant to 5-fluorouracil (FU) than CD133(+) cells, dependent on the β1-integrin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Prognostic role of CD133 expression in colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

HGF and SDF-1-mediated mobilization of CD133+ BMSC for hepatic regeneration following extensive liver resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5099-1

10.1245/S10434-016-5099-1

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

Dimensions Publication ID

0 references

1 reference

9 May 2018